The Smart Money Just Made a Move You Can’t Ignore
Steven Cohen’s Point72 quietly revealed a major stake — and the timing couldn’t be more critical.
When one of Wall Street’s most legendary hedge fund managers shows his hand, traders everywhere take notice. This month, Steven Cohen’s Point72 disclosed a significant new position in a beaten-down biotech stock. It’s the kind of move you rarely see — and it comes just as the chart presses against a major inflection point.
Enter your email below to get instant access to the free report.
That’s why we put together a brand-new report for you.
Inside, you’ll discover:
Get instant access to the free report.
Steve Strazza
Steve Strazza is Director of Research at All Star Charts, bringing a rare blend of Wall Street and technical expertise. He previously worked inside hedge funds, including Steve Cohen’s SAC Capital and Point72, before shifting his focus to price action and technical analysis. Today, Steve helps traders cut through the noise and spot high-conviction setups in U.S. equities.
Alfonso Depablos
Alfonso is a Market Strategist at All Star Charts, specializing in U.S. and international equities. He focuses on top-down technical analysis — using sector rotation, relative strength, and risk signals to uncover where money is flowing next. Alfonso holds the Chartered Market Technician (CMT) designation and brings a global perspective to every market he analyzes.
